In the future development process, Jiyinga will integrate global science and technology and medical wisdom, take "all for human health" as the concept, and rely on multi-omics platform to conduct big data research and transformation on important diseases that endanger human health at the omics level, and realize the vision of "maintaining health through genetic technology" through accurate omics assessment of human health.
Jiyinga Company focuses on precision medical treatment of tumor, and based on NGS detection and tumor gene big data in high-throughput sequencing, it lays out the whole chain of tumor prevention and treatment, and builds four business segments: clinical detection service, medical device manufacturing, scientific and technological cooperation service and tumor prevention and treatment service. The company's prospect is to become the most reliable cancer gene big data service platform.